[Fibrinogen degradation products in gynecologic neoplasms]
other
public-domain-us
AI-generated summary
Fibrinogen degradation products were elevated in over half of patients with malignant gynecologic tumors compared to healthy women and those with benign tumors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Concentration of fibrinogen degradation products in sera of 12 healthy women and 163 patients with gynecological tumors was determined by Staphylococcal-clumping-test. In sera of healthy women and patients with benign tumors the highest titer was 8. On the other hand in 53 of 97 cases with malign tumors higher concentrations were evaluated.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- pubmed
- last seen: 2026-05-14T05:58:58.463083+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine